Roche brings drug for small cell lung cancer to India
Drug firm Roche India on Thursday said it has launched Atezolizumab used for the treatment of small cell lung cancer in India after getting nod from Drugs Controller General of India. "Atezolizumab is the first cancer immunotherapy to receive an approval in India for the first line treatment of extensive-stage small cell lung cancer (ES-SCLC) when given in combination with chemotherapy," Roche India said in a statement.
The cancer immunotherapy harnesses the person's immune system to combat cancer more effectively for better results, it added. "Roche is committed to bring to India all the innovations being developed in its pipeline, to benefit patients," Lara Bezerra, chief purpose officer at Roche Products (India) said.
Launching Atezolizumab is an important step for small cell lung cancer patients in India, she added.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- India
- Roche India
- Lara Bezerra
- Drugs Controller General of India
ALSO READ
US Defense Secretary affirms commitment to bolster US-India partnership in Indo-Pacific to support allies' efforts.
US defence secretary reaffirms commitment to strengthening US-India partnership in supporting allies in Indo-Pacific region
Asian Wrestling Championships 2024: India's Udit wins silver; Abhimanyou, Vicky bag bronze
Border blurs at Zero Point in Jhakuatari on Eid, as locals from India, Bangladesh gather for Namaz
Badminton Asia Championships: PV Sindhu, HS Prannoy ousted, India's campaign ends